Titre:
  • CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: A retrospective substudy of the HERA trial (BIG 1-01)
Auteur:Pestalozzi, Bernhard Cornelius; Holmes, Eileen; Azambuja, Evandro; Metzger-Filho, Otto; Hogge, Laurence; Scullion, Matt; Lang, Istvan; Wardley, Andrew; Lichinitser, Mikhail; Sanchez, Roberto I Lopez; Müller, Volkmar; Dodwell, David; Gelber, Richard; Piccart-Gebhart, Martine; Cameron, David A
Informations sur la publication:Lancet oncology, 14, 3, page (244-248)
Statut de publication:Publié, 2013-03
Sujet CREF:Cancérologie
MeSH keywords:Adult
Aged
Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects
Antineoplastic Agents -- administration & dosage -- adverse effects
Breast Neoplasms -- drug therapy -- genetics -- mortality -- pathology
Central Nervous System Neoplasms -- chemically induced -- secondary
Chemotherapy, Adjuvant -- adverse effects
Clinical Trials as Topic
Disease-Free Survival
Female
Humans
Middle Aged
Neoplasm Staging
Receptor, ErbB-2 -- genetics
Recurrence
Retrospective Studies
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1470-2045
info:doi/10.1016/S1470-2045(13)70017-2
info:pii/S1470204513700172
info:scp/84875236228
info:pmid/23414588